No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

Aims/hypothesis Recent epidemiological studies suggest that treatment with insulin glargine (A21Gly,B31Arg,B32Arg human insulin) may promote cancer growth. The present meta-analysis was performed to assess the risk of cancer during treatment with insulin detemir (B29Lys(e-tetradecanoyl),desB30 human insulin), another long-acting insulin analogue.